Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A Look At Payers' Early Game Plans For Driving Biosimilar Use

Executive Summary

Interviews with US payers suggest that at first they are more likely to focus on promoting biosimilars in treatment-naïve patients, as opposed to switching those on branded drugs, according to a new Datamonitor report.

Advertisement

Related Content

Zarxio Coverage On Par With Innovators Even Without Interchangeable Designation
Ringside For Zarxio At Supreme Court: Biosimilar Stakeholders Line Up
Biosimilar Product Differences Will Affect US Uptake, Amgen Predicts
Biosimilars: Sandoz Pegfilgrastim Review, Amgen Adalimumab Launch Extended To 2018
UnitedHealthcare Prefers Basaglar Biosimilar At Lantus' Expense
Express Scripts Diabetes Program Caps Drug Costs, Targets Adherence
Rise Of The Biosimilar Formulary: CVS Excludes Lantus, Neupogen For 2017
Part B Reference Pricing Faces 'Clinical' As Well As 'Political' Obstacles

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS120243

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel